Evidence map›Paper›PMID 33523132›Full record

ArticleBioinformatics (Oxford, England)2021

A gene-level methylome-wide association analysis identifies novel Alzheimer's disease genes.

Chong Wu, Jonathan Bradley, Yanming Li, Lang Wu, Hong-Wen Deng

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chong WuDepartment of Statistics, Florida State University.
Jonathan BradleyDepartment of Statistics, Florida State University.
Yanming LiDepartment of Biostatistics & Data Science, University of Kansas Medical Center.
Lang WuPopulation Sciences in the Pacific Program, University of Hawaii Cancer center.
Hong-Wen DengTulane Center for Biomedical Informatics and Genomics, Deming Department of Medicine, Tulane University School of Medicine.

Funding

Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Ning Liu · 2016 to 2026
$25.3M
Trans-omics Integration of Multi-omics Studies for OsteoporosisU19AG055373 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI Qi Zhao · 2017 to 2026
$24.3M
Decoding Methylation Mediated Epigenomic Contributions to Male OsteoporosisR01AR069055 · NIAMS · TULANE UNIVERSITY OF LOUISIANA · PI DENG, HONG-WEN · 2017 to 2021
$2.9M
Integration of brain imaging with genomic and epigenomic dataR01MH104680 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI CALHOUN, VINCE D, DENG, HONG-WEN · 2014 to 2017
$2.1M
Novel Statistical Methods for Multi-omics Data Integration in Alzheimer's DiseaseR03AG070669 · NIA · FLORIDA STATE UNIVERSITY · PI BRADLEY, JONATHAN RAY, WU, CHONG · 2021 to 2022
$296k
NIAMS NIH HHS R01 AR069055NIA NIH HHS R03 AG070669NIA NIH HHS U19 AG055373NIGMS NIH HHS P20 GM109036NIMH NIH HHS R01 MH104680
6 · The paper itself

Abstract

motivationTranscriptome-wide association studies (TWAS) have successfully facilitated the discovery of novel genetic risk loci for many complex traits, including late-onset Alzheimer's disease (AD). However, most existing TWAS methods rely only on gene expression and ignore epigenetic modification (i.e., DNA methylation) and functional regulatory information (i.e., enhancer-promoter interactions), both of which contribute significantly to the genetic basis of AD.

resultsWe develop a novel gene-level association testing method that integrates genetically regulated DNA methylation and enhancer-target gene pairs with genome-wide association study (GWAS) summary results. Through simulations, we show that our approach, referred to as the CMO (cross methylome omnibus) test, yielded well controlled type I error rates and achieved much higher statistical power than competing methods under a wide range of scenarios. Furthermore, compared with TWAS, CMO identified an average of 124% more associations when analyzing several brain imaging-related GWAS results. By analyzing to date the largest AD GWAS of 71,880 cases and 383,378 controls, CMO identified six novel loci for AD, which have been ignored by competing methods. AVAILABILITY: Software: https://github.com/ChongWuLab/CMO. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Alzheimer DiseaseDNA MethylationGenome-Wide Association StudyEpigenesis, GeneticEpigenomeGenetic Predisposition to DiseaseHumansTranscriptome

Identifiers

PMID33523132
PMCPMC8337007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.